2383 related articles for article (PubMed ID: 26920550)
21. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
22. A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis.
Allan ERO; Campden RI; Ewanchuk BW; Tailor P; Balce DR; McKenna NT; Greene CJ; Warren AL; Reinheckel T; Yates RM
J Neuroinflammation; 2017 May; 14(1):103. PubMed ID: 28486971
[TBL] [Abstract][Full Text] [Related]
23. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH
PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
26. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
27. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
Peng W
Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
[TBL] [Abstract][Full Text] [Related]
28. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
Xu J; Wagoner G; Douglas JC; Drew PD
J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
[TBL] [Abstract][Full Text] [Related]
29. Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
Sonobe Y; Jin S; Wang J; Kawanokuchi J; Takeuchi H; Mizuno T; Suzumura A
Tohoku J Exp Med; 2007 Dec; 213(4):329-39. PubMed ID: 18075237
[TBL] [Abstract][Full Text] [Related]
30. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
[TBL] [Abstract][Full Text] [Related]
31. Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.
Schmidt CS; Zhao J; Chain J; Hepburn D; Gitter B; Sandusky G; Chintalacharuvu S; Glasebrook A; Na S
J Immunol; 2005 Aug; 175(4):2286-92. PubMed ID: 16081797
[TBL] [Abstract][Full Text] [Related]
32. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
33. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
[TBL] [Abstract][Full Text] [Related]
34. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
35. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
36. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
37. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
Yang EJ; Song IS; Song KS
Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383
[TBL] [Abstract][Full Text] [Related]
38. Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
Terényi N; Nagy N; Papp K; Prechl J; Oláh I; Erdei A
Mol Immunol; 2009 Nov; 47(1):57-63. PubMed ID: 19201476
[TBL] [Abstract][Full Text] [Related]
39. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.
Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG
Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338
[TBL] [Abstract][Full Text] [Related]
40. Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis.
Rajasundaram S
Front Immunol; 2018; 9():402. PubMed ID: 29559972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
